logo

VTAK

Catheter Precision·AMEX
--
--(--)
--
--(--)
1.01 / 10
Underperform

Corporate fundamentals rate poor at 1.0/10. Beneficial factors: Net profit attributable to parent company shareholders / Net profit (%) and Interest coverage ratio (EBIT / Interest expense) (%), however risks emerge in ROA (%) and Annualized net profit margin on total assets (%). Resultant assessment: defensive.

Fundamental(1.01)SentimentTechnical

Analysis Checks(2/5)

ROA (%)
Value-24.19
Score0/3
Weight30.98%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight10.41%
1M Return-1.71%
Annualized net profit margin on total assets (%)
Value-48.39
Score0/3
Weight30.98%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value6.37
Score2/3
Weight11.73%
1M Return-1.95%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight15.91%
1M Return-2.89%
Is VTAK fundamentally strong?
  • VTAK scores 1.01/10 on fundamentals and holds a Premium valuation at present. Backed by its -125.29% ROE, -2393.84% net margin, -0.13 P/E ratio, 0.49 P/B ratio, and 122.13% earnings growth, these metrics solidify its Underperform investment rating.